NASDAQ: XRTX
Xortx Therapeutics Inc Earnings Dates, Reports, Calls

Xortx Therapeutics earnings were -$2.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest XRTX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$431.0k, down 8.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XRTX reported annual earnings of -$1.9M, with -15.7% growth.

XRTX earnings history

Current Revenue
$0.0
Current Earnings
-$1.9M
Current Profit Margin
0%

XRTX Return on Equity

Current Company
-120.3%
Current Industry
-31.4%
Current Market
28.9%
XRTX's Return on Equity (-120.3%)... subscribe to Premium to read more.
High Return on Equity Performance

XRTX Return on Assets

Current Company
-90.5%
Current Industry
-9.6%
XRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XRTX announces earnings.

XRTX Return on Capital Employed

Current Company
-127.43%
Current Industry
-3.7%
XRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XRTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XRTX-$1.87M-$1.95MN/A-$2.06
AZTR-$10.49M-$10.96MN/A-$2.25
MTNB-$9.89M-$10.96MN/A-$2.00
SXTP-$7.27M-$7.86MN/A-$11.73
CANF-$9.76M-$9.83MN/A-$11.94

Xortx Therapeutics Earnings Reports & History FAQ

What were Xortx Therapeutics's earnings last quarter?

Xortx Therapeutics (NASDAQ: XRTX) reported Q4 2025 earnings per share (EPS) of -$0.22, up 163.11% year over year. Total XRTX earnings for the quarter were -$430.99 thousand. In the same quarter last year, Xortx Therapeutics's earnings per share (EPS) was $0.35.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.

Is Xortx Therapeutics profitable or losing money?

As of the last Xortx Therapeutics earnings report, Xortx Therapeutics is currently losing money. Xortx Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$1.94 million, a 15.73% decrease year over year.

What was XRTX's earnings growth in the past year?

As of Xortx Therapeutics's earnings date in Q2 2026, Xortx Therapeutics's earnings has grown year over year. XRTX earnings in the past year totalled -$1.95 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.